Japan, June 18 -- NEC Corporation, in collaboration with Chugai Pharmaceutical Co., Ltd., has conducted an experiment using AI to predict drug combinations that can possibly enhance the effectiveness of certain cancer treatments. As a result, the time required to produce predictions may potentially be reduced by approximately 50% when compared to Chugai's conventional methods.Drug combination therapy, in which two or more drugs are used in combination, is a promising option in the treatment of cancer. This therapy is expected to have a higher therapeutic effect than when single agents are administered. However, the prediction of drug combinations has conventionally required time-consuming manual research and analysis of information related ...